Decision Support · Side-by-side

iCAD ProFound Breast Health Suite vs Transpara Breast AI. Side by side.

Compare pricing, strengths, and use cases so it is easier to pick the right fit.

Browse alternatives Browse workflows

Change tools

Comparison Ready

iCAD ProFound Breast Health Suite

Best overall

Transpara Breast AI

Neither iCAD ProFound Breast Health Suite nor Transpara Breast AI is designed for everyday consumers—both are enterprise-grade medical tools for radiologists. The biggest difference is that iCAD offers more comprehensive risk evaluation and density assessment, while Transpara emphasizes seamless workflow integration and temporal comparison. For a non-technical person, neither tool is relevant; this comparison is for healthcare administrators evaluating breast cancer detection AI.

iCAD ProFound Breast Health Suite

#3140 of 3,826 Web

Transpara Breast AI

#3719 of 3,826 Web

Scores at a glance

iCAD ProFound Breast Health SuiteTranspara Breast AIPractical Versatility

Onboarding Ease

Ecosystem Fit

Market Value

Choose iCAD ProFound Breast Health Suite if

You run a large hospital or imaging center that needs a single tool for detection, density, and risk scoring
You want to reduce false positives to lower patient anxiety and callback rates
You have IT staff who can handle a multi-step integration with your existing PACS/EMR
You're willing to invest heavily upfront for a comprehensive breast health AI

Choose Transpara Breast AI if

Your clinic's main pain point is radiologist burnout and you need a tool to speed up reading
You want to compare current mammograms with previous ones to track changes over time
You prefer a vendor that offers regular algorithm updates and ongoing support after installation
You have a moderate budget and can afford the cost but need clearer pricing before committing

Key differences

iCAD covers risk evaluation and density assessment; Transpara focuses on detection and temporal comparison
iCAD reduces false positives more explicitly; Transpara emphasizes workload reduction
Transpara has a slightly more structured onboarding with regular check-ins; iCAD's process is more IT-heavy
Both lack mobile apps and APIs, so neither is usable on a phone or for custom integrations
iCAD works with both 2D and 3D mammograms; Transpara also supports both (FFDM and DBT)
Neither publishes pricing, making cost comparison impossible without a sales call

Facts side by side

	iCAD ProFound Breast Health Suite	Transpara Breast AI
Free plan
Mobile app
API access

iCAD ProFound Breast Health Suite: strengths & weaknesses

Covers three key tasks in one tool: cancer detection, density assessment, and risk evaluation
Reduces false positives, meaning fewer unnecessary callbacks for patients
Works with both 2D and 3D mammograms, fitting most modern clinics
No mobile app or API—you can't use it on a phone or integrate it with custom software
High upfront cost and unclear pricing make it risky for small clinics
Requires radiologist training and IT-heavy onboarding (6 steps) before you see value

Transpara Breast AI: strengths & weaknesses

Focuses on reducing radiologist workload by flagging suspicious areas quickly
Includes temporal comparison, letting doctors see how a breast changes over time
Onboarding is slightly more structured with ongoing support and algorithm updates
No mobile app or API—same limitation as iCAD for phone use or custom integrations
Cost is still a barrier for smaller clinics, and pricing isn't transparent
Risk of over-reliance on AI if radiologists trust it too much without double-checking

Common questions

Can I use iCAD ProFound Breast Health Suite or Transpara Breast AI on my phone?

No. Neither tool has a mobile app. They are designed to run on radiology workstations connected to hospital PACS systems, not on personal devices.

Which tool is better for a small clinic with a limited budget?

Neither is ideal. Both have high upfront costs and unclear pricing. Transpara may be slightly more accessible due to its focus on workflow efficiency, but you'll need to request a quote to know for sure.

Do these tools replace radiologists?

No. Both are decision-support tools that flag suspicious areas and provide scores. A radiologist must still review and make the final diagnosis. Over-reliance on AI is a known risk.

Which tool is easier to set up?

Transpara has a slight edge because its onboarding includes regular check-ins and algorithm updates. iCAD requires more IT-heavy steps like data migration and model configuration.

Can I integrate these tools with my existing electronic medical records (EMR)?

Both integrate with PACS and workstations, but neither lists specific EMR integrations. You'll need to consult with their sales teams to confirm compatibility with your system.

iCAD ProFound Breast Health Suite wins on versatility with risk evaluation and density assessment, but both tools are enterprise-only, expensive, and require radiologist training—not for everyday users.

If you're a healthcare administrator, start by requesting a demo from both vendors to get actual pricing and integration details. For most clinics, iCAD's broader feature set (risk evaluation + density) gives it an edge, but Transpara's workflow focus may be better if your main goal is speeding up readings. Neither is a casual purchase—plan for a significant time and money investment.

Visit iCAD ProFound Breast Health Suite Visit Transpara Breast AI

Detail pages: iCAD ProFound Breast Health Suite · Transpara Breast AI

iCAD ProFound Breast Health Suite

Transpara Breast AI

Free plan

Mobile app

API access